Related Experiment Video
Updated: Jul 15, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
Proteinase-activated receptor-2 (PAR2): a tumor suppressor in skin carcinogenesis
Anke Rattenholl1, Stephan Seeliger, Jörg Buddenkotte
1Department of Dermatology and Interdisciplinary Center for Clinical Research IZKF Münster, University of Münster, Münster, Germany.
Abstract:
The proteinase-activated receptor PAR(2) has been demonstrated to modulate tumor growth, invasion and metastasis in various tissues. However, the role of PAR(2) in cutaneous cancerogenesis is still unknown. Here we could show a protective role of PAR(2) in the development of epidermal skin tumors: we established a mouse skin tumor model using chemically induced carcinogenesis. Tumors started to appear after eight weeks. After 13 weeks, PAR(2)-deficient mice showed a significantly increased number of skin tumors (14 per animal on the average) in contrast to the wild type (eight tumors per mouse). Analysis of possible signal transduction pathways activated upon PAR(2) stimulation in HaCaT keratinocytes showed an involvement of extracellular signal-regulated kinase 1/2 and profound epidermal growth factor receptor transactivation, leading to secretion of the tumor-suppressing factor transforming growth factor-beta1. Thus, our results provide early experimental evidence for a tumor-protective role of PAR(2).
Insights
Proteinase-activated receptor 2 (PAR2) plays a protective role in skin cancer development. PAR2-deficient mice exhibited more skin tumors, indicating PAR2
Area of Science:
- Dermatology
- Oncology
- Molecular Biology
Background:
- Proteinase-activated receptor 2 (PAR2) is implicated in tumor modulation across various tissues.
- The specific function of PAR2 in the development of cutaneous cancers remains largely uncharacterized.
Purpose of the Study:
- To investigate the role of PAR2 in the development of chemically induced epidermal skin tumors.
- To elucidate the molecular mechanisms underlying PAR2's function in skin carcinogenesis.
Main Methods:
- A mouse model of chemically induced skin carcinogenesis was utilized.
- PAR2-deficient and wild-type mice were compared for tumor development over 13 weeks.
- Signal transduction pathways, including extracellular signal-regulated kinase 1/2 (ERK1/2) and epidermal growth factor receptor (EGFR) transactivation, were analyzed in HaCaT keratinocytes.
Main Results:
- PAR2-deficient mice developed a significantly higher number of skin tumors (average of 14 per animal) compared to wild-type mice (average of 8 per animal) after 13 weeks.
- PAR2 stimulation in keratinocytes activated ERK1/2 and EGFR transactivation.
- This activation led to the secretion of transforming growth factor-beta1 (TGF-β1), a known tumor-suppressing factor.
Conclusions:
- PAR2 exhibits a tumor-protective role in the development of epidermal skin tumors.
- PAR2 signaling, through ERK1/2 and EGFR transactivation, promotes the secretion of TGF-β1, contributing to tumor suppression.
More Related Videos
07:13Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
07:53Visualization and Quantitative Analysis of Genotoxin-Induced PARP1/PARP2 Activation in Cells Using a Fluorescent Fusion Protein-Based Reporter
Published on: April 17, 2026
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...